Physician
Physical Medicine/Rehab
Dr. Paul A. Nausieda, MD
|
|
Give Review
Paul Nausieda practices Physical Medicine/Rehab. He researched medicine at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10 in research and 19 in primary care medicine Paul Nausieda is a published doctor. He published 64 publications, including: 'Treatment and prognosis of hemiballismus.' He is registered with Medicare and accepts Medicare payments.
Publications
- Conversion to IPX066 from Standard Levodopa Formulations in Advanced Parkinson's Disease: Experience in Clinical Trials.
- A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkin...
- [18F]-Dopa positron emission tomography imaging in early-stage, non-parkin juvenile Parkinsonism.
- LSD and other related hallucinogens elicit myoclonic jumping behavior in the guinea pig.
- An open multicenter trial of Sinemet CR in levodopa-naive Parkinson's Disease patients.
- Parkinsonism: is your treatment appropriate?
- Dystonic foot response of Parkinsonism.
- Opsoclonic cerebellopathy: A paraneoplastic Syndrome responsive to thiamine.
- Carbidopa-levodopa ratio in Parkinson's Disease.
- Drug-induced asterixis in Parkinson Disease.
- The effect of chronic levodopa on haloperidol induced behavioral supersensitivity in the guinea pig.
- Practical guidelines for drug holidays in parkinsonian patients.
- Complications of chronic levodopa therapy: long-term efficacy of drug holiday.
- Pemoline-induced Chorea.
- Drug holiday and management of Parkinson Disease.
- The pharmacological evaluation of pergolide mesylate as a potential anti-parkinson agent.
- Correlation between daily dosage of chlorpromazine and subsequent supersensitivity.
- Sydenham Chorea: an update.
- Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis.
- Parkinsonian features and Progressive supranuclear palsy.
- Meige's syndrome during long-term dopaminergic therapy in Parkinson's Disease.
- Tardive dyskinesia: pharmacology and clinical implications.
- Weekly drug holiday in Parkinson Disease.
- The effect of bromocriptine (BCT) on the on-off phenomenon.
- Long-term suppression of central serotonergic activity by corticosteroids: a possible model of steroid-responsive myoclonic Disorders.
- Modification of central serotonergic and dopaminergic behaviors in the course of chronic corticosteroid administration.
- Effect of chronic levodopa on haloperidol-induced behavioral supersensitivity in the guinea pig.
- Levodopa-free periods ("drug holidays") in the management of Parkinsonism.
- Serotonergically active agents in levodopa-induced psychiatric Toxicity reactions.
- Psychiatric complications of levodopa therapy of Parkinson's Disease.
- Chronic dopaminergic sensitivity after Sydenham's Chorea.
- Tourette-like symptoms following chronic neuroleptic therapy.
- Meige syndrome (blepharospasm-oromandibular Dystonia) after long-term neuroleptic therapy.
- Influence of female sex hormones on neuroleptic-induced behavioral supersensitivity.
- Sinemet "abusers".
- Treatment and prognosis of hemiballismus.
- Effect of chlorphromazine on central Nervous system concentrations of manganese, iron, and copper.
- Long-term prognosis in transient global amnesia.
- Paradoxial response to dopaminergic agents in Parkinsonism.
- Dopamine binding following prolonged haloperidol pretreatment.
- Phenytoin and choreic movements.
- Respiratory dyskinesias: extrapyramidal dysfunction and dyspnea.
- Levodopa-induced dopamine receptor hypersensitivity.
- Chorea induced by oral contraceptives.
- Modification of postsynaptic dopaminergic sensitivity by female sex hormones.
- Bromocriptine: decreased clinical effects at higher dosages.
- Amphetamine-induced hypersensitivity in guinea pigs.
- Methylphenidate-induced Chorea: case report and pharmacologic implications.
- The effect of lithium on an animal model of tardive dyskinesia.
- Bromocriptine-induced behavioral hypersensitivity: implications for the therapy of Parkinsonism.
- The effect of levodopa, lergotrile, and bromocriptine on Brain iron, manganese, and copper.
- Lergotrile in the treatment of Parkinsonism.
- Effect of pergolide mesylate, an ergoline, in animal models of Parkinson''s Disease: implications for therapy.
- Clinical and experimental studies of phenytoin-induced hyperkinesias.
- The specificity of neuroleptic- and methysergide-induced behavioral hypersensitivity.
- Clonazepam and 5-hydroxytryptophan-induced myoclonic stereotypy.
- Gilles de la Tourette Syndrome after long-term chlorpromazine therapy.
- Levodopa-induced dopaminergic hypersensitivity in the pathogenesis of psychiatric and neurologic Disorders.
- Recent advances in the biochemical pharmacology of extrapyramidal movement Disorders.
- Dopaminergic antagonism of L-5-hydroxytryptophan-induced myoclonic jumping behavior.
- Too many treatments for Parkinson's Disease: how should they be used?
- Quantitative analysis of Tremors in welders.
- Ropinirole 24-hour prolonged release and ropinirole immediate release in early Parkinson''s Disease: a randomized, double-blind, non-inferiority crossover study.
Schools
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Michael Reese Hospital Med Center
University Of Chicago Hosps
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Cerebral Artery Thrombosis
- View All
Doctors Specialties
- Neurology
- Physical Medicine/Rehab
Accepted Insurances
Education
-
University of Chicago -
University of Chicago Pritzker School of Medicine
Hospital
-
Aurora Sinai Medical Center
Drug Facts
| NPI NUMBER | 1932146412 | |
| NPPES Provider LastName | NAUSIEDA | |
| NPPES Provider FirstName | PAUL | |
| NPPES Provider ZIPCode | 532331305 | |
| NPPES Provider State | WI | |
| Specialty Description | Neurology | |
| Total Claim Count | 6608.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 39.0 | |
| Percent Opioid Claims | 0.59 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1932146412 |
| Last Name Of The Provider | NAUSIEDA |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
|
Dr. Jennifer N. Klopfstein, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Feng Lu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paula S. Benes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David S. Dahl, MD |
|
|
Dr. Theresa M. Braun, MD |
|
|
Dr. Donna D. Davidoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul R. Sandford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shrikant Tele, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anjum M. Razzaq, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel I. Matsuo Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina A. Jenner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Serena Thompson, MD |